நிறுவனம் ஆஃப் மருத்துவ ஜெநெடிக்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிறுவனம் ஆஃப் மருத்துவ ஜெநெடிக்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிறுவனம் ஆஃப் மருத்துவ ஜெநெடிக்ஸ் Today - Breaking & Trending Today

German program using whole genome sequencing to diagnose rare diseases and cancer risk


German program using whole genome sequencing to diagnose rare diseases and cancer risk
A program at the University Hospital of Tübingen is the first in Germany to use whole genome sequencing (WGS) to improve the diagnosis of rare diseases and hereditary cancers.
The program is led by Professors Tobias Haack and Olaf Riess from the Institute of Medical Genetics and Applied Genomics. While they will use whole genomes to diagnose rare conditions, they will also use the information to generate scores for the risk of common diseases based on genomic data - polygenic risk scores. A polygenic risk score is a risk estimation of developing a disease based on the total number of genetic changes related to that disease. They say that this data will help identify individuals that may benefit from personalized healthcare management. ....

Baden Wuberg , Olaf Riess , Sven Schaffer , Tobias Haack , Institute Of Medical Genetics , Professors Tobias Haack , Medical Genetics , Ge Med Project , Professor Riess , Markets Amp Regulations , Rare Disease , Whole Genome Sequencing , ஓலேஃப் ரீஎஸ்ஸ் , ஸ்வெந் ஶேஃபர் , டோபியாஸ் ஹேக் , நிறுவனம் ஆஃப் மருத்துவ ஜெநெடிக்ஸ் , ப்ரொஃபெஸ்ஸர்ஸ் டோபியாஸ் ஹேக் , மருத்துவ ஜெநெடிக்ஸ் , கே மேட் ப்ராஜெக்ட் , ப்ரொஃபெஸர் ரீஎஸ்ஸ் , சந்தைகள் ஆம்ப் ஒழுங்குமுறைகள் , ரேர் நோய் , முழு மரபணு வரிசைப்படுத்துதல் ,

Some sperm use poison to outrace their competitors


Some sperm use poison to outrace their competitors
By
(0)
Researchers say that the sperm wining the race to the egg often effectively poisons its competitors on the way. File Photo by Sebastian Kaulitzki/Shutterstock
Feb. 4 (UPI) It turns out that the sperm that win the race to the egg use variants of genetic factors, called distorters, to poison their competitors, according to new research.
Experiments with mouse models suggest a genetic factor called t-haplotype is essential to the production of progressive sperm the ones capable of winning the race
Advertisement
T-haplotype genes regulate the synthesis of a molecule called RAC1, and the experiments detailed Thursday in the journal PLOS Genetics showed progressive sperm motility requires just the right amount of RAC1. ....

Alexandra Amaral , Bernhard Herrmann , Institute Of Medical Genetics , Max Planck Institute For Molecular Genetics , Max Planck Institute , Molecular Genetics , Medical Genetics , Human Genetics , அலெக்சாண்ட்ரா அமரல் , பெர்ன்ஹார்ட் ஹெர்மன் , நிறுவனம் ஆஃப் மருத்துவ ஜெநெடிக்ஸ் , மூலக்கூறு ஜெநெடிக்ஸ் , மருத்துவ ஜெநெடிக்ஸ் , மனிதன் ஜெநெடிக்ஸ் ,